S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65

Bod Australia Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume75,095 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive BDA News and Ratings via Email

Sign-up to receive the latest news and ratings for Bod Australia and its competitors with MarketBeat's FREE daily newsletter.

About Bod Australia

Bod Australia Limited operates as a cannabis centric healthcare company in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It offers medicinal cannabis, cannabidiol (CBD), and hemp healthcare products. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.


See More Headlines

Industry, Sector and Symbol

Household & Personal Products
Year Founded

Sales & Book Value

Annual Sales
$7.42 million
Book Value
A$0.08 per share





Next Earnings Date
Not Optionable


Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Bod Australia (ASX:BDA) Frequently Asked Questions

What stocks does MarketBeat like better than Bod Australia?

Wall Street analysts have given Bod Australia a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bod Australia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Bod Australia's earnings last quarter?

Bod Australia Limited (ASX:BDA) posted its earnings results on Thursday, February, 28th. The company reported ($0.05) EPS for the quarter.
View Bod Australia's earnings history

Who are Bod Australia's key executives?

Bod Australia's management team includes the following people:
  • Ms. Joanne Patterson, CEO, Exec. Director & Member of Medical Advisory Board
  • Mr. Craig Weller, COO & Member of Medical Advisory Board
  • Mr. Alan Dworkin, Chief Financial Officer
  • Dr. Adele Hosseini, Chief Scientific Officer & Member of Medical Advisory Board
  • Mr. Stephen Kelly, Company Sec.

What other stocks do shareholders of Bod Australia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bod Australia investors own include Syrah Resources (SYR), MGC Pharmaceuticals (MXC), Medlab Clinical (MDC), Lynas Rare Earths (LYC), iSignthis (ISX), Eclipx Group (ECX), Botanix Pharmaceuticals (BOT) and AusCann Group (AC8).

What is Bod Australia's stock symbol?

Bod Australia trades on the ASX under the ticker symbol "BDA."

How much money does Bod Australia make?

Bod Australia has a market capitalization of $0.00 and generates $7.42 million in revenue each year.

What is Bod Australia's official website?

The official website for Bod Australia is bodaustralia.com.

How can I contact Bod Australia?

The company can be reached via phone at 61 2 9199 5018.

This page was last updated on 10/19/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.